Medical Journal Abstracts

Overview

Medical Journal Abstracts

The medical journal abstracts section provides healthcare professionals with access to key journal abstracts. Bringing together articles from a full range of sources, this resource aims to provide doctors with a starting point for their journal research.

The regularly updated journals can be sorted by disease/condition, source name and the date of publication. Alternatively they can be accessed within the relevant epgonline.org disease topic areas, via the collapsible menu at the top of each page of the epgonline.org website.

 

Latest Medical Journal Abstracts

Psoriasis

-174 days ago -  Psoriasis

This review emphasizes the pathologic features of psoriatic lesions, recent genetic studies of psoriasis, and immunologic factors in the disease. The evolution of a psoriatic lesion entails a ...

Imatinib: a breakthrough of targeted therapy in cancer.

-102 days ago -  Imatinib: a breakthrough of targeted therapy in cancer.

Deregulated protein tyrosine kinase activity is central to the pathogenesis of human cancers. Targeted therapy in the form of selective tyrosine kinase inhibitors (TKIs) has transformed the approach ...

Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?

-18 days ago -  Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?

Anti-EGFR therapy and antiangiogenic therapies are used alone or in combination with chemotherapies to improve survival in metastatic colorectal cancer. However, it is unknown whether pretreatment ...

Prognostic Impact of IL-6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy.

4 days ago -  Prognostic Impact of IL-6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy.

Background: The IL-6/STAT3 axis promotes inflammation, angiogenesis, and cancer. The effect of genetic variants within this pathway on benefit from anti-angiogenic cancer therapy is unknown. We ...

Aprepitant for postoperative nausea and vomiting: a systematic review and meta-analysis.

5 days ago -  Aprepitant for postoperative nausea and vomiting: a systematic review and meta-analysis.

Postoperative nausea and vomiting (PONV) is an important clinical problem. Aprepitant is a relatively new agent for this condition which may be superior to other treatment. A systematic review was ...

The role of autologous stem cell transplantation in primary CNS lymphoma.

5 days ago -  The role of autologous stem cell transplantation in primary CNS lymphoma.

Primary CNS lymphoma (PCNSL) treatment includes two phases: induction and consolidation. Induction consists of high-dose-methotrexate-based polychemotherapy for most patients, with regimen and dose ...

Eventual role of EGFR-tyrosine kinase inhibitors in early-stage non-small-cell lung cancer.

5 days ago -  Eventual role of EGFR-tyrosine kinase inhibitors in early-stage non-small-cell lung cancer.

Nonadvanced non-small-cell lung cancer (NSCLC) has a poor long-term survival from surgery or definitive radiation that is minimally improved with induction/adjuvant conventional chemotherapy. ...

Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring.

5 days ago -  Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring.

Disease overview: Chronic Myeloid Leukemia (CML) is a myeloproliferative neoplasm with an incidence of 1-2 cases per 100,000 adults. It accounts for approximately 15% of newly diagnosed cases of ...

Second-line single-agent chemotherapy in human epidermal growth factor receptor 2-negative metastatic breast cancer: A systematic review.

5 days ago -  Second-line single-agent chemotherapy in human epidermal growth factor receptor 2-negative metastatic breast cancer: A systematic review.

Background: No 'gold standard' exists for single-agent chemotherapy of human epidermal growth factor receptor 2-negative (HER2-negative) metastatic breast cancer (MBC) in the second-line. ...

Ibrutinib as a Bruton Kinase Inhibitor in the Management of Chronic Lymphocytic Leukemia: A New Agent With Great Promise.

5 days ago -  Ibrutinib as a Bruton Kinase Inhibitor in the Management of Chronic Lymphocytic Leukemia: A New Agent With Great Promise.

The recent discovery of the role of the B-cell antigen receptor (BCR) signaling pathway in the propagation and maintenance of both normal B-cell function and in B-cell malignancies has highlighted ...

Journals by Disease Topic

Browse medical journal abstracts by selecting from disease topic. Alternatively click the “View All” button to access our entire database to filter Medical Journal Abstracts by year.

Browse Medical Journal Abstracts by Year

Browse medical journal abstracts by year, then further select by month for the latest medical abstracts and articles available.

Back to top